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Abstract: Purpose: Evidence regarding functional impairment in people with severe mental
disorders (SMD) is sparse in low and middle-income countries. The aim of this study
was to identify factors associated with functional impairment in people with enduring
SMD in a rural African setting.
Methods: A cross-sectional study was conducted at the baseline of a health service
intervention trial. A total of 324 participants were recruited from an existing community-
ascertained cohort of people with SMD (n= 218), and attendees at the Butajira General
Hospital psychiatric clinic (n= 106). Inclusion criteria defined people with SMD who had
ongoing need for care: those who were on psychotropic medication, currently
symptomatic or had a relapse in the preceding two years. The World Health
Organization Disability Assessment schedule (WHODAS-2.0) and the Butajira
Functioning Scale (BFS), were used to assess functional impairment. Multivariable
negative binomial regression models were fitted to investigate the association between
demographic, socio-economic and clinical characteristics, and functional impairment.
Results: Increasing age, being unmarried, rural residence, poorer socio-economic
status, symptom severity, continuous course of illness, medication side effects and
internalized stigma were associated with functional impairment across self-reported
and caregiver responses for both the WHODAS and the BFS. Diagnosis per se was
not associated consistently with functional impairment.
Conclusion: To optimize functioning in people with chronic SMD in this setting, services
need to target residual symptoms, poverty, medication side effects and internalized
stigma. Testing the impact of community interventions to promote recovery will be
useful. Advocacy for more tolerable treatment options is warranted.
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In the multivariable models, problematic khat use was associated only with increasing caregiver-reported 
BFS scores.” 
4. Why is religion mentioned as significant in the results section of the manuscript (P12) but not in the 
discussion or conclusion sections of the manuscript? 
As the reviewer correctly indicated, we presented, in the results section, that “Christian religion was 
associated with lower functional impairment”. Nevertheless, we did not want to take this further and give 
Authors' Response to Reviewers' Comments Click here to download Authors' Response to Reviewers'
Comments Responses to reviewers comments_re-review.docx
space in the discussion section. We did this intentionally because this is not a finding relevant to the study 
context. In the study setting, although the majority of the participants were Muslims (76.2%), there is no 
difference between Christians and Muslims in terms of their occupation, education level and socio-
economic conditions.  So, we believed that religion is not a relevant contextual factor that would affect 
functional impairment of people with severe mental disorder.  
5. The spacing for Reference 50 needs to be corrected. 
Thank you for the meticulous review and identifying errors at this greater detail. We have now manually 
corrected the spacing for reference 50.  
 
 
 
 
1 
 
Functional impairment among people with severe and enduring mental 1 
disorder in rural Ethiopia: A cross-sectional study 2 
Kassahun Habtamu1*, Atalay Alem2, Girmay Medhin3, Abebaw Fekadu2, 4, Charlotte Hanlon2, 5 3 
1School of Psychology, College of Education and Behavioral Studies, Addis Ababa University, 4 
Addis Ababa, Ethiopia 5 
2Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa 6 
University, Addis Ababa, Ethiopia  7 
3Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia 8 
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Department of 9 
Psychological Medicine, Centre for Affective Disorders, London, UK 10 
5Kings College London, Institute of Psychiatry, Psychology and Neuroscience, Health Services 11 
and Population Research Department, Centre for Global Mental Health, London, UK  12 
 13 
Email addresses of authors: 14 
KH: Kasshabmek@gmail.com 15 
AA: atalay.alem@gmail.com 16 
GM: gtmedhin@yahoo.com 17 
AF: abe.wassie@kcl.ac.uk 18 
CH: charlotte.hanlon@kcl.ac.uk 19 
 20 
 21 
 22 
*Correspondence: Kassahun Habtamu, School of Psychology, College of Education and 23 
Behavioral Studies, Addis Ababa University, Addis Ababa, Ethiopia; P.O.BOX: 1176; 24 
Telephone: +251-911-697732; Email: Kasshabmek@gmail.com.  25 
ORCiD number: https://orcid.org/0000-0001-8619-9388 26 
 27 
Manuscript Click here to download Manuscript Main manuscript_After re-
review .docx
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
Acknowledgments  1 
We are grateful to all the participants for giving their time and the data. We would also like to 2 
acknowledge the TaSCS (Task Sharing the Care of People with Severe Mental Disorders) project 3 
outreach workers for helping to recruit and inviting the participants.  4 
Funding 5 
This research was conducted as part of the Africa Focus on Intervention Research for Mental 6 
Health (AFFIRM). Research reported in this publication was funded by the National Institute of 7 
Mental Health (NIMH) of the National Institutes of Health (NIH) under Award Number 8 
U19MH095699. The content is solely the responsibility of the authors and does not necessarily 9 
represent the official views of the National Institutes of Health. 10 
KH is supported by a post-doctoral fellowship from the African Mental Health Research 11 
Initiative (AMARI). AMARI is part of the DELTAS Africa Initiative [DEL-15-01]. The 12 
DELTAS Africa Initiative is an independent funding scheme of the African Academy of 13 
Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and 14 
supported by the New Partnership for Africa’s Development Planning and Coordinating Agency 15 
(NEPAD Agency) with funding from the Wellcome Trust [DEL-15-01] and the UK government. 16 
The views expressed in this publication are those of the author(s) and not necessarily those of 17 
AAS, NEPAD Agency, WellcomeTrust or the UK government. 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
ABSTRACT 1 
Purpose: Evidence regarding functional impairment in people with severe mental disorders 2 
(SMD) is sparse in low and middle-income countries. The aim of this study was to identify 3 
factors associated with functional impairment in people with enduring SMD in a rural African 4 
setting.  5 
Methods: A cross-sectional study was conducted at the baseline of a health service intervention 6 
trial. A total of 324 participants were recruited from an existing community-ascertained cohort of 7 
people with SMD (n= 218), and attendees at the Butajira General Hospital psychiatric clinic (n= 8 
106). Inclusion criteria defined people with SMD who had ongoing need for care: those who 9 
were on psychotropic medication, currently symptomatic or had a relapse in the preceding two 10 
years. The World Health Organization Disability Assessment schedule (WHODAS-2.0) and the 11 
Butajira Functioning Scale (BFS), were used to assess functional impairment. Multivariable 12 
negative binomial regression models were fitted to investigate the association between 13 
demographic, socio-economic and clinical characteristics, and functional impairment.  14 
Results: Increasing age, being unmarried, rural residence, poorer socio-economic status, 15 
symptom severity, continuous course of illness, medication side effects and internalized stigma 16 
were associated with functional impairment across self-reported and caregiver responses for both 17 
the WHODAS and the BFS. Diagnosis per se was not associated consistently with functional 18 
impairment.   19 
Conclusion: To optimize functioning in people with chronic SMD in this setting, services need 20 
to target residual symptoms, poverty, medication side effects and internalized stigma. Testing the 21 
impact of community interventions to promote recovery will be useful. Advocacy for more 22 
tolerable treatment options is warranted.  23 
Key words: Severe mental disorder, disability, low and middle income countries, schizophrenia, 24 
bipolar disorder, major depressive disorder  25 
 26 
 27 
 28 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
 
Background  1 
Severe mental disorders (SMD), including schizophrenia, bipolar disorder and major depressive 2 
disorder with psychotic features, can be highly disabling illnesses [1-3]. The functional 3 
impairment seen in these conditions includes the compromised ability to work, to engage in 4 
interpersonal relationships, to care for oneself, and to participate in community activities [4]. In 5 
large, representative cohorts of people with schizophrenia in Finland [5], impairment in social 6 
functioning was present in more than 80% of participants. In a  comparative study of manic or 7 
hypomanic, euthymic and depressed patients and healthy controls, 30 to 50% of people with 8 
bipolar disorder experienced significant social disability [6]. Data from the World Health Survey 9 
indicates that major depressive disorder results in the greatest disability compared with other 10 
chronic physical diseases [7].  11 
There are very few population-based studies on the functional outcome of SMD from low- and 12 
middle-income countries (LMICs). The level of functioning of a population-based study of 13 
people with schizophrenia, bipolar disorder and severe major depressive disorder in rural 14 
Ethiopia was significantly lower than the normative value for the general population [8-10]. In 15 
studies comparing the level of functional impairment in different diagnostic categories, a mixed 16 
picture emerges, with some finding greater impairment in people with schizophrenia [11,12] and 17 
other studies showing that symptom severity was more predictive of functional impairment than 18 
clinical diagnosis [13,14]. 19 
Several studies, mostly from high income countries, identified factors that are associated with 20 
functional impairment in people with SMD: socio-demographic characteristics (male sex, older 21 
age, single or divorced marital status, urban residence, and lower socio-economic status) [15-18], 22 
illness characteristics (severity of negative and positive symptoms, long duration of untreated 23 
psychoses, co-morbid substance abuse, medication side effects, psychotic symptoms in the 24 
previous episode, low pre-morbid functioning, the number of prior episodes, prior hospital 25 
admissions, and younger age of onset) [13,15,19-23], social characteristics (lack of social 26 
support and stigma) [24,25] and cognitive impairment [4,26,27]. The association of symptom 27 
severity, medication side effects, stigma, and cognitive impairment with functional impairment is 28 
consistent across studies [17].  29 
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There is generally a lack of evidence regarding factors that are associated with functional 1 
impairment among people with SMD in LMICs. This study aimed, therefore, to elucidate the 2 
association of demographic, economic, social and clinical factors with functional impairment of 3 
people with enduring SMD in a rural African setting in order to inform service planning and 4 
development. In view of findings of previous studies and our own qualitative explorations and 5 
observations, we hypothesized that diagnostic category, severity of symptoms, medication side 6 
effects and internalized stigma would be associated with functional impairment in people with 7 
SMD.  8 
Methods  9 
Study design  10 
The cross-sectional baseline data of the TaSCS (Task Sharing the Care of Severe Mental 11 
Disorders) trial [28] was used in this analysis. The aim of the TaSCS trial is to determine the 12 
effectiveness and cost-effectiveness of task-sharing mental health care for people with SMD in 13 
primary health care, compared to psychiatric nurse-led mental health care [29].  14 
Study setting and context  15 
The study was conducted in the town of Butajira and surrounding districts, located around 16 
130km south of Addis Ababa, the capital city of Ethiopia. The study area is found in the Gurage 17 
and Silti Zones of the Southern Nations, Nationalities and People’s Region (SNNPR) of 18 
Ethiopia. Although there are both urban and rural dwellers, the area is predominantly rural. The 19 
area has diverse climatic and topographic features. Farming is the main means of livelihood in 20 
rural areas, whereas small scale trading is common in the towns. While maize is the main 21 
subsistence grain in the lowland areas, khat and chili pepper are the main cash crops. The 22 
highlanders mainly live on “kocho” (bread made from false banana trees). The area is also 23 
diverse in terms of ethnic identity with predominance of the Gurage and Silti ethnic groups. The 24 
majority of the population is either Muslim or Orthodox Christian by religion. Mental health 25 
research has been ongoing in the Butajira area for over 15 years. It is the site for a large, 26 
population-based cohort study looking at the course and outcome of schizophrenia, bipolar 27 
disorder and major depressive disorder [30], known as the Butajira SMD study. The TaSCS trial 28 
was nested within the Butajira SMD study after the study had been running for around 12 years. 29 
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People in the Butajira area use both traditional and biomedical treatment methods for their 1 
mental health problems. At the time of this study, biomedical mental health care was limited to 2 
the out-patient psychiatric unit at Butajira General Hospital. This service was provided by two 3 
psychiatric nurses. 4 
Participants and recruitment  5 
The details of the characteristics of the sample and the recruitment procedure have been reported 6 
elsewhere [28]. Nevertheless, we briefly described the sample and the recruitment procedure as 7 
follows. Participants were recruited from the Butajira SMD cohort and from attendees at the 8 
Butajira General Hospital psychiatric out-patient clinic. Initially, our plan was to recruit the 9 
sample from the Butajira SMD cohort because it was community ascertained, but we did not 10 
have a big enough sample for the study. So, that is why we then decided to recruit also from the 11 
Butajira General Hospital psychiatric outpatient clinic. Inclusion criteria defined people with 12 
enduring SMD who had a need for ongoing care: those who were on psychotropic medication, 13 
currently symptomatic or had experienced relapse in the preceding two years. The sample size 14 
for the study was 324. A total of 218 participants were recruited from 507 people who were in 15 
the Butajira SMD cohort. Among those who were in the cohort, 40 refused, 32 were not 16 
contactable, 187 had no ongoing need for mental health care, 2 were restrained at home, 1 was 17 
mourning a loss, 4 had died, 2 were profoundly deaf, 1 was imprisoned, 2 had just given birth, 10 18 
were too unwell to be transported to screening site, 7 lacked capacity to consent and actively 19 
refused and 1 caregiver was not willing to bring the patient for screening. Only three potentially 20 
eligible participants refused to participate. The remaining participants  (n=106) were recruited 21 
from consecutive attendees at the psychiatric clinic at Butajira General Hospital who had been in 22 
contact with services for at least two years, were aged 25 to 65 years and who resided in the 23 
geographical catchment area of the Butajira SMD study. Twelve people who were screened and 24 
potentially eligible did not consent to participate. We considered the criteria about age and time 25 
since illness started to make the two sub-samples more similar. Also, most important is that both 26 
sub-samples were defined in relation to needing ongoing care. 27 
For participants recruited from the Butajira SMD study, historical diagnosis of SMD at the time 28 
of recruitment for the cohort was made using Schedules for Assessment in Neuropsychiatry 29 
(SCAN) [31]. For recruits from the Butajira General Hospital psychiatric out-patient clinic, new 30 
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SCAN diagnoses were made by psychiatrists who had been trained by a psychiatrist who had 1 
training at an accredited SCAN training centre.  2 
In addition to service users, we also included caregivers in our sample. Caregivers were defined 3 
as close family members (parents, sons/daughters, siblings or husband/wife) who were living 4 
with the person with SMD. After we finished recruiting the service users, we determined the 5 
caregiver of each service user using the above criteria.  6 
Assessment of functional impairment  7 
The 12 item version of the World Health Organization Disability Assessment Schedule 8 
(WHODAS-2.0) and the Butajira Functioning Scale (BFS) were used to assess functional 9 
impairment. The WHODAS is a generic, non-health condition specific, cross-cultural measure of 10 
activity limitations and social restrictions of a person in the past 30 days [32,33]. It is available in 11 
12 and 36 item versions, can be self-administered or interviewer administered and responses can 12 
be provided by the person with the health condition, a caregiver or a clinician [34,35]. The 13 
psychometric properties of the WHODAS have been established in a number of studies [36-39]. 14 
The WHODAS has also been adapted and validated in different languages and cultures 15 
[33,35,40], including in the rural Ethiopian setting [41]. The BFS is a local functioning scale 16 
developed for people with SMD in a rural African context and piloted in the district where the 17 
current study was conducted. The BFS was developed following standard procedures, including 18 
a qualitative study [42], review of previous scales, free listing and pile sorting exercise, expert 19 
consensus, cognitive interviewing and pilot testing. The BFS has 33 shared items for men and 20 
women and 8 women-only items in three domains: self-care, work and social functioning [43]. 21 
The BFS is easy and fast to administer, with excellent internal consistency, construct and 22 
convergent validity and acceptable sensitivity to change over time. We used both the WHODAS 23 
and the BFS to assess functional impairment because we found in our previous validation studies 24 
[41,43] in that the two instruments complement with each other. Both the WHODAS and the 25 
BFS were administered to service users and caregivers.   26 
Clinician-administered measures 27 
The expanded version of the Brief Psychiatric Rating Scale (BPRS-E) was used to assess 28 
symptom severity. BPRS-E is a 24- item clinician administered symptom scale, which covers 29 
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four domains of symptoms of SMD (positive symptoms, negative symptoms, anxiety and 1 
depressive symptoms and manic excitement or disorganization) [44]. The BPRS-E has been used 2 
widely to detect clinical improvement in response to an intervention [45]. BPRS-E has been used 3 
previously in Ethiopia [43,46]. Psychiatric nurses who received training and ongoing supervision 4 
administered the BPRS-E. They were found to have good inter-rater reliability.   5 
The Composite International Diagnostic Interview (CIDI) substance abuse module was used to 6 
assess khat use. The CIDI substance abuse module is a fully structured interview that ascertains 7 
the diagnosis of alcohol, tobacco and nine classes of psychoactive drugs. Excellent Kappa values 8 
for individual alcohol and drug symptoms have been reported for the CIDI substance abuse 9 
module [47]. Problematic khat use was operationalized in this study as endorsing any of the 10 
items of the CIDI relating to khat abuse or dependence. The Mini International Neuropsychiatric 11 
Interview (MINI) Suicidality Scale was used to assess self-harm and suicidal behaviors, 12 
including thought, intent and attempt. Each item is scored yes or no and weighted according to 13 
its estimated contribution to risk level. The MINI Suicidal Scale has been shown to be valid as a 14 
screen for the risk of suicidal behaviors [48]. Medication side effects were assessed using the 15 
Antipsychotic Side effects Checklist (ASC). The ASC was designed to assess a range of 16 
commonly encountered side-effects of antipsychotic medications. Clinical characteristics, 17 
including the course of psychosis and number of psychotic episodes were determined using the 18 
Life Chart Schedule (LCS) [49]. 19 
Lay-interviewer administered measures 20 
Self-stigma was assessed using the Internalized Stigma of Mental Illness (ISMI) scale. The ISMI 21 
is a 29 item scale designed to measure the subjective experience of stigma, with five sub-scales 22 
(alienation, stereotype endorsement, perceived discrimination, social withdrawal, and stigma 23 
resistance) [50]. The ISMI has high internal consistency and test-retest reliability, and with good 24 
evidence  in its convergent and construct validity [51]. The ISMI scale has been used across a 25 
wide range of languages and cultures [50]. The ISMI was used in a previous facility-based study 26 
in Ethiopia and found to have good construct validity and internal consistency [52]. An eight 27 
item, structured self-reported medication adherence measure, the Morisky Medication Adherence 28 
Scale [53], was employed to assess the extent to which patients were adherent to their respective 29 
medication. A structured self-report demographic, social and economic characteristics 30 
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questionnaire was used to collect data on sex, age, urban-rural residence, ethnic group, religion, 1 
marital status, educational status, ownership of household assets, food security and self-2 
sufficiency and relative wealth of the participants. Experienced diploma holder data collectors 3 
were trained for two days to administer the lay-interviewer administered measures. 4 
Data management and analysis  5 
Data were double entered into an electronic Case Report Form using OpenClinica [54]. Data 6 
analysis took place using Stata Version 13. Frequencies and percentages were used to summarize 7 
categorical, socio-demographic and clinical characteristics, whereas mean and standard deviation 8 
were used for summarizing the continuous variables. Negative binomial regression models, for 9 
service user reported and caregiver reported scores of the WHODAS and the BFS, were fitted 10 
separately in order to see consistency of findings. Multivariable negative binomial regression 11 
models were fitted to assess the association of demographic, social, economic and clinical factors 12 
with functional impairment in people with SMD. We used negative binomial regression because 13 
WHODAS and BFS scores were not normally distributed and only non-negative integer values 14 
are possible. Crude and adjusted relative risks (RR) were used to estimate the strength of 15 
association between the independent and dependent variables. All statistical tests were set at α = 16 
0.05 for significance. 17 
Ethical considerations  18 
Ethical approval for the TaSCS trial was obtained from several international and local institutes: 19 
the Institutional Review Board of the College of Health Sciences, Addis Ababa University 20 
(Reference Number 030/12/Psy), the AHRI-ALERT Ethics Review Committee (Reference 21 
Number P037/13), the National Research Ethics Review Committee of Ethiopia (Reference 22 
Number 3.10/758/07), the Food, Medicine and Health Care Administration and Control 23 
Authority of Ethiopia (Reference Number 02/6/22/13), the University of Cape Town Human 24 
Research Ethics Committee (Reference Number 226/2011) and the United States of America’s 25 
National Institute of Mental Health Data Safety and Monitoring Board (DSMB). Written 26 
informed consent was obtained from most of the participants after the nature of the study and the 27 
information sought had been fully explained. The study included a few people (n= 10) with SMD 28 
who lacked capacity to consent to participate, were not actively refusing and had a guardian to 29 
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give permission. During the study period, participants were provided with free treatment for both 1 
their mental and physical health problems.  2 
Results  3 
Characteristics of the participants  4 
A total of 324 people with SMD participated in the study. Socio-demographic characteristics are 5 
presented in Table 1. Of the total sample, 47.1% (n=137) had schizophrenia, 35.5% (n= 116) had 6 
bipolar disorder and 21.9% (n=71) had major depressive disorder. Nearly half of the participants 7 
had either a continuous (27.5%) or episodic (20.1%) course for psychotic symptoms. Three 8 
quarters of participants receiving medication reported one or more medication side effects; 9 
13.6% of the participants reported suicidal ideation in the past one month; and 6.8% reported 10 
problematic khat use. See Table 1. 11 
Factors associated with WHODAS-2.0 scores  12 
The mean score of the service user responses of the WHODAS was 22.3 (SD= 9.0) and of the 13 
caregiver responses was 24.7 (SD= 10.6) out of the maximum score of 60. Results from both the 14 
univariate and multivariable negative binomial regression models of the service user and 15 
caregiver reported WHODAS scores are presented in Table 2. In the multivariable model of 16 
service user reported WHODAS scores, increasing age, rural residence, being unmarried, lower 17 
perceived relative wealth, major depressive disorder, continuous course for psychosis, increasing 18 
scores of BPRS-E, increasing scores of internalized stigma and reporting two or more medication 19 
side effects were significantly associated with greater functional impairment.  20 
In the multivariable model of caregiver reported WHODAS scores, the same factors were found 21 
to be associated with functional impairment. However, major depressive disorder, continuous 22 
course for psychosis and lower perceived relative wealth were not significantly associated. 23 
Christian religion was significantly and negatively associated with functional impairment.  24 
Factors associated with BFS scores  25 
The mean score of the service user responses from the BFS was 65.7 (SD= 28.5) and of the 26 
caregiver responses 76.4 (SD= 33.8) out of the maximum score of 165. Results from the 27 
univariate and multivariable negative binomial regression models of service user and caregiver 28 
reported BFS scores are presented in Table 3. As with the WHODAS, we found increasing age, 29 
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being unmarried, lower perceived relative wealth, continuous course of psychosis, increasing 1 
scores of BPRS-E, increasing scores of internalized stigma and two or more medication side 2 
effects to be associated with greater functional impairment. However, while increasing scores of 3 
MINI Suicidal Scale scores were found to be associated with greater functional impairment in 4 
addition to the above factors, rural residence and major depressive disorder were not 5 
significantly associated.   6 
In the multivariable model of caregiver reported BFS scores, the same factors were significantly 7 
associated with functional impairment. Nevertheless, Christian religion was significantly 8 
associated with lower functional impairment and rural residence and problematic khat use were 9 
significantly associated with greater functional impairment. Continuous course of psychosis, 10 
increasing age and MINI Suicidal Scale scores were not associated with functional impairment.  11 
Discussion  12 
In this cross-sectional study of people with enduring SMD in a rural African setting, increasing 13 
age, being unmarried, rural residence, perceived lower relative wealth, continuous course of 14 
psychosis, higher symptom severity, internalized stigma and two or more medication side effects 15 
were consistently and significantly associated with functional impairment. Service user reported 16 
and caregiver reported scores on both the cross-cultural WHODAS and the contextually valid 17 
BFS measures gave similar patterns of associations. The study identified symptom severity, 18 
continuous course of psychosis, internalized stigma and medication side effects as important 19 
factors associated with functional impairment in people with severe and enduring SMD. The 20 
study confirmed that risk factors of functional impairment in people with SMD from high 21 
income country settings are also found to be important in LMIC settings.  22 
A negative association was found between the diagnostic category of bipolar disorder and 23 
caregiver reported WHODAS scores and between both bipolar disorder and major depressive 24 
disorder and service user reported BFS scores, when compared to schizophrenia. In the 25 
multivariable models, however, a significant association was found only between major 26 
depressive disorder and service user reported WHODAS scores. Our sample was selected on the 27 
basis of needing ongoing mental health care, which might explain the similarity in level of 28 
functional impairment across diagnostic groups. Nonetheless, our finding is in keeping with the 29 
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evidence base [11-13,22], which indicates that the severity of symptoms, medication side effects, 1 
stigma and cognitive impairment are more important than diagnosis to predict functional 2 
impairment [17].  3 
Among the socio-demographic factors considered in this study, increasing age and rural 4 
residence were positively associated with greater functional impairment, whereas being married 5 
was associated with lower levels of functional impairment. This is consistent with previous 6 
Ethiopian studies [8-10] and studies from elsewhere in the world [17]. Activity limitations and 7 
restrictions in participation are likely to increase with increasing age of living with severe mental 8 
illness due to deterioration of independent living skills, restricted social relationships, and 9 
comorbid medical and mental health conditions [55]. These may arise from the illness itself, 10 
medication side effects and stigma and discrimination. With regards to marital status, married 11 
people are likely to have the necessary social support to be more functional; and in addition to 12 
this there is also a likely social obligation to engage in several social activities compared to 13 
unmarried people. There is also a possibility that this association is due to reverse causality, in 14 
that better functioning people are more likely to get married and stay married. Our finding that 15 
people from rural areas are likely to have more functional impairment than urban residents is 16 
contrary to the widely held assumptions [56]. One possible explanation is that the kinds of 17 
activities rural residents are expected to perform, such as farming, are more difficult than 18 
activities of urban residents who are engaged in petty trade, office work or other small scale 19 
businesses. Therefore, rural residents are more likely to report difficulties of accomplishing those 20 
activities. An alternative explanation could be our use of culturally validated measures of 21 
functioning which are able to detect functional impairment in this rural setting. Residual 22 
confounding by socio-economic status might also contribute to the observed association. 23 
Contrary to our expectation, economic variables, including composite scores obtained from 24 
several asset indicators as well as indicators of food security and self-sufficiency were not found 25 
to be associated with functional impairment, both in the univariate and multivariable analyses. 26 
Previous cross-sectional studies found that lower socio-economic status was associated with 27 
greater functional impairment, particularly in the interpersonal domain [57] and higher socio-28 
economic status was associated with functional recovery [58]. Low variability in the 29 
socioeconomic status in this rural low-income setting may have contributed.  Furthermore, we 30 
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only used a one-item crude indicator of food insecurity; in a neighbouring district, using a 1 
validated scale to measure food insecurity, an association between disability and food insecurity 2 
was observed in people with SMD [59]. However, the consistent association between lower 3 
perceived relative wealth and functional impairment is in keeping with our previous qualitative 4 
study [42] which suggested that  the impact of SMD on functioning may be moderated by 5 
economic status.  6 
Of the clinical characteristics considered, symptom severity and medication side effects were 7 
positively associated with functional impairment consistently in all the models estimated. There 8 
is generally a lack of evidence on the impact of medication side effects on the day to day 9 
functioning of people with SMD. Only first-generation antipsychotic medications are available in 10 
the study site, with a reportedly high burden of sedative and movement-related side effects [60]. 11 
In our previous qualitative study [42], service user and caregiver participants emphasized 12 
medication side effects as important factors for the day-to-day functioning of people with SMD. 13 
Another qualitative study in the same setting [61] found that medication side effects might 14 
contribute to non-adherence due to a desire to preserve functioning over symptom control. 15 
However, medication adherence was not found to be associated with functional impairment in 16 
our study. This may be attributed to our sample; we included stabilized people with SMD who 17 
had been in mental health care for more than 15 years. The other reason may be because Butajira 18 
SMD study participants were followed-up by project outreach workers who provided support 19 
with medication adherence. Our reliance on a self-report measure of adherence may also have 20 
under-estimated non-adherence due to social desirability bias. Although this is not consistent 21 
across measures and respondents, problematic khat use was associated with greater functional 22 
impairment. More specifically, in the univariate models, problematic khat use was associated 23 
with increasing patient-reported and caregiver-reported WHODAS scores and increasing 24 
caregiver-reported BFS scores. In the multivariable models, problematic khat use was associated 25 
only with increasing caregiver-reported BFS scores. There is lack of evidence regarding the 26 
association between khat use and functional impairment in people with SMD. A previous 27 
qualitative study in the same setting as this study found that people with SMD use khat to try to 28 
improve functioning [62]. This may be a reflection of reverse causality or perhaps khat does not 29 
actually improve functioning. 30 
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The association between clinical or illness related characteristics and functional impairment that 1 
we found in this study is consistent with the literature. A recent prospective cohort study among 2 
people with severe mental illnesses in China found a strong association between symptom 3 
severity and levels of functioning [23]. Bottlender and colleagues [13] concluded that the 4 
severity of illness symptoms and not the diagnosis of a mental disorder is the most significant 5 
factor in determining the level of functional impairment. In a ten year prospective study [19], 6 
participants with more severe psychotic symptoms demonstrated significantly more impairment 7 
in occupational functioning, irrespective of diagnosis. Hence, our findings emphasize the 8 
importance of achieving symptom remission and dealing with medication side effects as crucial 9 
aspects of the recovery process.  10 
This study indicated that there is consistency between the responses obtained from the 11 
WHODAS and BFS measures in the kinds of factors that are found to be associated with 12 
functional impairment. Consistent association was found between symptom severity, internalized 13 
stigma, medication side effects and poverty with scores of functional impairment obtained from 14 
the WHODAS or the BFS. This is expected since our validation study of the BFS found that the 15 
two instruments have strong convergent validity [43]. Minor differences between the BFS and 16 
WHODAS relate to the association with diagnosis, MINI Suicidality scores and Khat use.  The 17 
MINI Suicidality score was associated with scores on the service user reported BFS scores. 18 
Problematic Khat use was associated with the caregiver reported BFS scores. These differences 19 
indicate that the BFS, as a contextual and disease specific measure, may be more sensitive than 20 
the WHODAS. 21 
In order to optimize the functioning of people with SMD who have ongoing need for mental 22 
health care, it may be useful to deal with the factors that are found to be consistently associated 23 
with functional impairment. For instance, community level rehabilitation services may help to 24 
improve family life and reduce stigma [63]. Mental health care services need to be expanded and 25 
give attention to controlling residual symptoms and medication side effects. Improved access to 26 
care (providing care closer to home) may affect the adequacy of symptom control [28]. There is 27 
a need for advocacy services by mental health researchers and professionals and civic 28 
organizations such as mental health service user organizations for more choice of medication and 29 
service expansion. 30 
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Strengths and limitations 1 
Strengths of the study include use of standardized clinician evaluations for assessment of the key 2 
clinical variables, rigorous data management and use of a community-based population for our 3 
study. In addition, functional impairment was measured using two instruments: a standard, cross-4 
cultural and locally validated instrument and a locally developed scale which was found to be 5 
contextually relevant. Responses for the outcome variable were also obtained from both service 6 
users and caregivers. Our use of two functional impairment measures and responses from service 7 
users and caregivers bring consistency to the study findings. Most of the previous studies assess 8 
functional impairment with only one instrument and obtain responses only from service users. 9 
Nevertheless, the following limitations need to be taken into account while interpreting the 10 
findings of this study. Our study is cross-sectional, and therefore the direction of association 11 
cannot be determined. We were not able to measure cognitive impairment, which is found to be 12 
consistently and strongly associated with functional impairment in several previous studies [27]. 13 
Other potential confounders, such as lifestyle factors, were not measured and adjusted in the 14 
regression models. The medication side effect scale has not been validated in the rural Ethiopian 15 
context. We used two types of sample in this study: the Butajira SMD cohort and attendees at the 16 
Butajira General Hospital psychiatric out-patient clinic. The first is a community sample while 17 
the latter is a clinical sample which may not represent the general population. Those who come 18 
to the clinic for seeking treatment may be different from those who did not and this may bring 19 
about selection bias.  20 
Conclusions  21 
In order to optimize functioning in people with chronic SMD in this setting, services need to 22 
target residual symptoms, poverty, medication side effects and internalized stigma. Testing the 23 
impact of adjunctive community-based interventions to promote inclusion and recovery will be 24 
useful. Advocacy for less sedating medication options is also warranted. Further research is 25 
required, in rural low income country settings, to elucidate the prospective association of socio-26 
demographic, socio-economic and clinical characteristics with functional impairment in people 27 
with SMD.  28 
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